Medical scrubs and uniform manufacturer
Sales have fallen from pandemic highs, and non-product costs have risen roughly 30%, S&P Global Ratings analysts
As of June 25, the company has borrowed $80 million under its $100 million revolving credit line.
S&P estimates that Careismatic’s earnings before interest, taxes, depreciation and amortization fell by more than 35% ...
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.
